New hope for tough leukemias: experimental drug LBS-007 enters human testing
Disease control
Recruiting now
This study tests an experimental drug called LBS-007 in adults with acute leukemias (AML or ALL) that have returned or not responded to standard treatments. The main goals are to find a safe dose and see if the drug can control the disease. About 90 participants will receive the …
Phase: PHASE1, PHASE2 • Sponsor: Lin BioScience, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC